Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1991-12-20
1992-12-08
Daus, Donald G.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514212, 5142278, 5142372, 514316, 514327, 540488, 540524, 544 584, 544129, 546188, 546216, A61K 31445
Patent
active
051698447
ABSTRACT:
Inhibition of the enzymes cholesterol ester hydrolase (CEH) and/or acyl coenzyme A: cholesterol acyltransferase (ACAT) results in inhibition of absorption of cholesterol and thus lowers serum cholesterol levels. Compounds of the formula below: ##STR1## where R.sup.1 is selected from alkyl, alkenyl, cycloalkyl, cycloalkylalkyl or arylalkyl and R.sup.2 is hydrogen or alkyl or --NR.sup.1 R.sup.2 is morpholine, thiomorpholine or 4-substituted or unsubstituted piperidine and R.sup.3, R.sup.4, R.sup.5, R.sup.6 are hydrogen, alkyl, alkoxy, halogen, nitro, cyano, perhaloalkyl, alkanoyloxy, alkoxycarbonyl or hydroxycarbonyl have been shown to inhibit the enzymes CEH and/or ACAT in in vitro tests to inhibit absorption of radio-labeled cholesterol in rats.
REFERENCES:
patent: 3322818 (1967-05-01), Hanze
patent: 4060609 (1977-11-01), Schacht et al.
patent: 4139620 (1979-02-01), Boswell
Bhat et al., Biochem. Biophys. Res. Commun. 109, 486 (1982).
Gallo et al., J. Lipid Research, 25, 604 (1984).
Hosie et al., J. Biol. Chem. 262, 260 (1987).
Stout et al., Biochem. Biophys. Acta, 837, 6 (1985).
Field, J. Lipid Research, 25, 389 (1984).
Cayen et al., J. Lipid Research, 20, 162 (1979).
Foldes et al., J. Pharmacol. Exptl. Therap. 122, 457-464 (1958).
Sumida et al., Plant & Call Physiol. 14, 781-785 (1973).
van den Berg et al., Pestic. Sci. 13, 19-38 (1982).
Derwent Abstract 81-55962-D of Japanese Patent J56071-058.
Commons Thomas J.
Strike Donald P.
American Home Products Corporation
Boswell, Jr. Robert F.
Daus Donald G.
LandOfFree
4-substituted piperidinecarboxylic acid esters: inhibition of ch does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 4-substituted piperidinecarboxylic acid esters: inhibition of ch, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 4-substituted piperidinecarboxylic acid esters: inhibition of ch will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-961154